Changes in several extracellular matrix proteins, such as fibronectin in fetal membrane and cervical collagens, occur at term and preterm delivery. However, no studies have evaluated changes in extracellular matrix proteins, in relation to myometrial activation recorded using invasive techniques during parturition in any species. We used suppression subtractive hybridization (SSH), to demonstrate the dramatic increases in one extracellular matrix protein, thrombospondin-1 (TSP1), in the pregnant ovine myometrium associated with parturition. Myometrial poly-A ϩ RNA, extracted from term control ewes not in labor at 143-147 days of gestational age (dGA, n ϭ 4), and from ewes in spontaneous term labor (STL) at 145-147 dGA (n ϭ 4), was subjected to SSH to construct a subtracted myometrial complementary DNA library. A complementary DNA clone from myometrial subtracted library, representing differentially expressed gene in the pregnant sheep myometrium during STL, was identified as TSP1 by sequence analysis and Blastn search. This cloned TSP1 was used to perform Northern blot analysis on total RNA isolated from five early controls, not in labor, at 130 dGA, five pregnant ewes in betamethasone-induced premature labor (BPL) at 130 dGA (betamethasone administered iv to the fetus at 0.48 mg over 48 h), six termcontrol-not-in-labor ewes at 143-147 dGA, and six pregnant ewes in STL. Northern blot analysis demonstrated that TSP1 increased significantly, associated with both BPL and STL. TSP1 protein level paralleled the increase of TSP1 messenger RNA during BPL and STL. To determine whether increase in this gene paralleled the increased strength of myometrial contractility, six ewes were treated with nimesulide, a selective PG synthase 2 inhibitor, at 147-148 dGA. Nimesulide infusion to the ewe iv to inhibit myometrial contraction (30 mg bolus, followed by 5 h infusion, 30 mg/h) commenced 9 h after onset of labor at 147-148 dGA. TSP1 in the myometrium decreased when myometrial contraction was inhibited by nimesulide. Both in situ hybridization and immunocytochemistry demonstrated that fibroblasts and the smooth muscle cells contained TSP1 messenger RNA and protein. TSP1 was also localized in the extracellular matrix. Our conclusions are: 1) our data provide the first evidence that changes in TSP1 are associated with myometrial activation in pregnant sheep during term and preterm labor; 2) myometrial fibroblasts and the smooth muscle cells are responsible for producing TSP1; and 3) SSH is a powerful technique that enables us to study differentially regulated genes during labor. (Endocrinology 140: 2364 -2371, 1999) P REMATURE birth is a major problem of pregnancy, accounting for 75% of perinatal mortality and 50% of long-term morbidity (1). The development of therapeutic regimens that will effectively prevent preterm birth awaits a greater understanding of the mechanisms that regulate labor. A more profound understanding of the parturition requires integration of processes that maintain pregnancy and inhibit parturition, as well as mechanisms that activate and stimulate myometrial contraction.
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The switch in myometrial contractility patterns, from contractures to contractions (2, 3) , is accompanied by myometrial activation (1) involving changes in expression of a collection of contraction-associated proteins. Contraction-associated proteins that have been investigated during late gestation and labor in sheep and other species include: the estrogen receptor (4, 5) ; the steroid receptor-associated proteins-heat shock proteins 70 and 90 (Hsp 70 and 90) (6) ; oxytocin (OT) (7) (8) (9) ; agonist receptors-OT receptors (10 -13) , PG receptors (14 -16) , gap junction proteins (17, 18) , and ion channels (19, 20) . Once activated, the myometrium can respond to paracrine and endocrine stimulation by uterotonic agonists (e.g. OT and PGs) that bring labor to a successful conclusion.
Based on these observations, others and we (1, 21) have proposed that the onset of labor is associated with preparation of the myometrium, with resultant changes in a cassette of genes (up-or down-regulation). Each member of the cassette of genes contributes, to some extent, in the switch in myometrial contractility patterns from contractures to contractions, as well as the progression of established labor. Altered abundance of members of this cassette of genes in the myometrium is a prerequisite for labor and delivery. Myometrial activation before and during labor seems to play a critical role in connecting fetal signals that indicate fetal readiness for birth, to maternal factors that carry labor forward to expel the fetus.
Understanding of the molecular basis of myometrial activation is incomplete. More information is needed on the genes involved during labor and the factors regulating their expression. To understand the molecular basis of myometrial activation, the relevant subsets of differentially expressed genes associated with the various stages of parturition must be identified, cloned, and studied in detail. Suppression subtractive hybridization (SSH) is a powerful approach to identify and isolate complementary DNAs (cDNAs) of differentially expressed genes. In the present study, we employed this sensitive and powerful technique to identify unknown factor(s), which may play important roles in the process of parturition. Improved understanding of the cellular processes that occur at labor will advance our knowledge of the key regulatory mechanisms involved in preparation for and development of parturition.
Using SSH, we identified a marked increase at the messenger RNA (mRNA) level associated with parturition in one extracellular matrix protein, thrombospondin-1 (TSP1, a glycoprotein) in the pregnant ovine myometrium. The increase in TSP1 mRNA level was accompanied by increased TSP1 protein level, measured by Western blot analysis. We also examined the cellular distribution of TSP1 mRNA, in relation to its protein expression in the pregnant sheep myometrium, using in situ hybridization and immunocytochemistry.
Materials and Methods

Animals and tissue collection
Twenty-eight pregnant Rambouillet-Dorset ewes from the University flock, bred on a single occasion and carrying fetuses of known gestational age, were studied. Experimental procedures were approved by the Cornell University Institutional Animal Care and Use Committee. The Cornell facilities are approved by the American Association for the Accreditation of Laboratory Animal Care. At 120 days of gestational age (dGA), ewes from which tissues were obtained were instrumented with electromyogram (EMG) leads, sewn into the myometrium, and fetal and maternal carotid arterial and jugular venous catheters (2) . Labor was defined as having occurred when the myometrial EMG record showed a clear switch from contractures to contractions, followed by contraction activity for at least 5 h (22) .
Myometrium was obtained from ewes, during labor, in a comparative study to determine whether there were any differences in labor induced by the infusion of betamethasone [Celestone phosphate, ScheringPlough Corp. (Kenilworth, NJ), n ϭ 5]. Betamethasone (10 g/h) was administered iv into the fetal jugular vein continuously over a period of 48 h, in a total dosage of 0.48 mg, to precipitate betamethasone-induced premature labor (BPL). Ewes underwent necropsy at 130 dGA, when they went into labor as a result of the betamethasone administration. Myometrium was also obtained from contemporary control ewes (n ϭ 5) at the same stage of gestation (130 dGA). These ewes were designated as early controls, not in labor (ECNL). Fetuses of ECNL ewes were infused with physiological saline. These ewes were not in labor, because the myometrial EMG showed only contractures and no contractions. Tissues were also collected from ewes in spontaneous term labor (STL) at 145-147 dGA (n ϭ 6), and term control ewes not in labor (TCNL; n ϭ 6) at the same gestational age (143-147 dGA).
Nimesulide infusion. Nimesulide (D-5648; Sigma Chemical Co., St. Louis, MO) was prepared in DMEM at a concentration of 1.25 mg/ml. Nimesulide infusion to the ewe (n ϭ 6) iv (30 mg bolus, followed by 6 h infusion, 30 mg/h) commenced 9 h after onset of labor, at 147-148 dGA.
Myometrium was always removed from the ventral aspect of the midportion of the body of the uterus and frozen in liquid nitrogen for later RNA extraction. Another similar portion of the myometrium was embedded in Tissue Freezing Medium (Triangle Biomedical Science, Durham, NC) and frozen in liquid-nitrogen-cooled isopantane for later study by in situ hybridization analysis and immunocytochemistry. Frozen tissues were stored at Ϫ80 C.
Construction of subtracted cDNA library
Total RNA and poly-A ϩ RNA isolation. Total RNA was isolated from myometrium of the sheep in STL and TCNL, as described previously (4) . Briefly, total RNA was isolated from frozen tissues by homogenization in 4.2 m guanidinium thiocyanate solution. RNA was pelted through a 5.7 m cesium chloride cushion. The RNA purity and recovery of each tissue was determined by UV spectrophotometry (260 and 280 nm). Poly-A ϩ RNA was extracted from total RNA using the MicroFastTrack kit as suggested by the manufacturer (Invitrogen, San Diego, CA). The poly-A ϩ RNA from the two groups (TCNL and STL) was purified in parallel using the same reagents and protocol.
cDNA subtraction library. SSH (23) was used to construct subtraction library to identify up-expressed genes in the STL myometrium. The library was made using PCR-Select cDNA Subtraction Kit, according to the protocol provided by the manufacturer (CLONTECH Laboratories, Inc., Palo Alto, CA). Briefly, the SSH protocol is as follows: poly-A ϩ RNA from STL and TCNL were designated as tester and driver, respectively. The double-strand cDNAs were synthesized from 2 g myometrial poly-A ϩ RNA obtained from both STL and TCNL ewes. The synthesized double-strand cDNAs were then digested with restriction enzyme RsaI. The digested blunt ends of the tester cDNA (from STL) were divided into two parts and ligated with two different cDNA adaptors. Two cycles of hybridization were followed after the ligation. In the first cycle, excess driver cDNAs (from TCNL) were added to the two populations of tester cDNAs after denaturation, to achieve equalization and enrichment of differentially expressed sequences in the hybridization solution. During the second hybridization process, denatured fresh driver cDNAs were added into the two tester cDNA populations again and allowed to anneal, to further enrich the differentially expressed sequences. The final hybridization solution (also called the subtracted library) was employed as a template to amplify the differentially expressed sequences in the tester population by using a set of PCR primers and was followed by nested PCR primers. Both sets of PCR primers were annealed to the different sites of ligated adaptors. The secondary PCR amplification, by using nested primers, considerably enriched the differentially expressed sequences and reduced background of PCR product (23) .
The amplified cDNA fragments from the secondary PCR were ligated into a pCR2.1 vector using a T/A cloning kit (Invitrogen). Positive clones were identified by differentially screening the subtracted library using both forward-subtracted and reverse-subtracted probes (derived by switching between tester and driver populations for another subtractive hybridization). The forward-subtracted and reverse-subtracted probes, labeled with ␣-32 P deoxycycidine triphosphate (dCTP), were hybridized with the replicate cDNA library dot blots (Gene Screen Plus membrane, NEN Research Products, DuPont NEN, Boston, MA). Positive clones, identified by differential screening, were cultured in LB medium to obtain plasmid DNA for sequencing. The plasmid DNA was purified using the Biorobot system (Qiagen, Chatsworth, CA), and sequencing was done by Taq cycle sequencing using DyeDeoxy terminators in an automated sequencer (ABI 377 DNA sequencer; PE Applied Biosystems, Foster City, CA) at the core sequencing facility of Cornell University. The cloned fragments were sequenced from at least two different clones and from both the coding and noncoding strands. The acquired sequence data were aligned against the GenBank nucleotide database at the National Center for Biotechnology Information (National Institutes of Health, Bethesda, MD) using Blastn to search for sequence matches.
Identification of TSP1 as an up-regulated gene in parturition.
The Blastn search revealed that three of the up-regulated gene clones were homologous to ovine TSP1. Because it was isolated from the tester cDNA population (STL myometrium), it represented the up-regulated gene from the myometrium of the pregnant sheep during labor. The acquired sequence data were aligned against the GenBank nucleotide database and revealed that the clones contain partial coding and most downstream sequences of TSP1 mRNA. The cloned ovine TSP1 fragment was then used as a cDNA probe for Northern blot analysis and in situ hybridization, as described below.
Northern blot analysis
Total RNA was prepared from individual tissues, as described above. Samples of total RNA (30 g/lane) from each tissue were denatured in 17.4% (vol/vol) formaldehyde, 50% (vol/vol) formamide, 20 mm 3-(Nmorpholino) propanesulfonic acid), 5 mm sodium acetate, and 1 mm EDTA (pH 7.0) for 5 min at 65 C and separated on a 1% (wt/vol) agarose/0.66 m formaldehyde gel. Ethidium bromide-stained ribosomal RNA (rRNA) bands were visualized (UV) to ensure that RNA degradation had not occurred and that an equal amount of RNA had been loaded into each lane. After electrophoresis, RNA was transferred to a nylon membrane (Gene Screen Plus; DuPont NEN, Wilmington, DE) by capillary blotting for 24 h in 10 ϫ SSC (1 ϫ SSC is 0.15 m NaCl and 0.015 m Na Citrate, pH 7.0). Completion and uniformity of transfer were assessed by determining transfer of 28S and 18S rRNA from the gel. Membranes were prehybridized at 42 C for 5 h in hybridization solution [50% (vol/vol) deionized formamide, 50 mm sodium phosphate, 0.8 m NaCl, 2% (wt/vol) SDS, 100 g salmon sperm DNA/ml, 20 g transfer RNA/ml, and 1 ϫ Denhard's (50ϫ ϭ 1% solution of BSA, Ficoll, and polyvinylpyrrolidone).
The cloned ovine TSP1 cDNA fragment was labeled with ␣-32 P dCTP (for Northern blot analysis) and labeled with ␣- 35 S dCTP (for in situ hybridization) using the random priming method (DuPont NEN) to specific activities of approximately 1 ϫ 10 9 cpm/g and used at a final concentration of 1 ϫ 10 6 cpm specific probe/ml of hybridization solution.
Hybridization was carried out at 42 C for 20 h in hybridization solution containing the specific TSP1 cDNA probe. Membranes were washed sequentially in 2 ϫ SSC at room temperature for 10 min, and 0.5 ϫ SSC with 0.1% SDS at 65 C for 30 min. Kodak X-OMAT AR film (obtained from Sigma Chemical Co.) was exposed to the membrane with intensifying screens at Ϫ80 C. Exposure durations were varied to achieve hybridization signals within the limited linear range for densitometry.
Membranes were stripped of TSP1 probe by boiling in 0.1 ϫ SSC with 0.1% (wt/vol) SDS for 30 min and rehybridized with ␣-32 P dCTP-labeled 18S cDNA probe to normalize TSP1 mRNA levels. Autoradiographed signals were quantified by Scan densitometry.
In situ hybridization
In situ hybridization was performed as described previously (13), with some modification. Frozen sections of pregnant sheep myometrium were cut and mounted on poly-l-lysine-coated slides. Tissue sections were fixed in freshly prepared 4% paraformaldehyde in 10 mm PBS (pH 7.2) for 10 min, followed by 2 ϫ PBS wash, 5 min each, at room temperature. Prehybridization was performed at 42 C for 1 h in prehybridization buffer containing 50% formamide, 5 ϫ SSPE (1 ϫ SSPE being 0.18 m NaCl, 10 mm NaH 2 PO 4 , and 1 mm EDTA), 0.1% SDS, 0.1% (vol/vol) Denhardt's solution, 200 g denatured salmon testis DNA/ml, and 200 g transfer RNA/ml. Hybridization was carried out for 18 h at 42 C in hybridization buffer [prehybridization buffer plus 4% (wt/vol) dextran sulfate] containing 1.0 ϫ 10 6 cpm 35 S-labeled ovine TSP1 cDNA probe/ section. After hybridization, the sections were rinsed at room temperature for 2 h in 2 ϫ SSC, 2 h in 1 ϫ SSC, 1 h in 0.5 ϫ SSC, and finally for 1 h in 0.5 ϫ SSC at 37 C. The sections were then dehydrated by passing through an alcohol series, containing 300 mm ammonium acetate, and coated with liquid photographic emulsion (NTB2, Kodak). After 10 days exposure, the sections were developed and stained with hematoxylin and eosin. 
Controls
Serial sections were treated with pancreatic ribonuclease (RNase) A (20 g/ml), for 30 min at room temperature, before hybridization. After enzyme treatment, the sections were rinsed in three changes of 2 ϫ SSC (5 min each) and hybridized with the ␣-35 S dCTP-labeled ovine TSP1 cDNA probe, as described above.
Western blot analysis
Cytosolic extracts. Myometrium was ground into small pieces and then homogenized in Tris buffer [50 mm Tris (pH 7.4), 10 mm EDTA, and 1 mm diethyldithi-ocarbamic acid], containing 2 mm octyl glucoside, and was centrifuged at 30,000 ϫ g for 20 min at 4 C. The 30,000 ϫ g supernatant (cytosol) was retained and stored at Ϫ80 C until used for electrophoretic analyses. The protein concentration was determined by the method of Bradford (Bio-Rad Laboratories, Inc., Hercules, CA).
The cytosolic proteins (50 g/lane) were then separated by 10% SDS-PAGE and were electrophoretically transferred to a nylon membrane (Imobilon, Millipore Corp., Bedford, MA) using a transfer blot cell (Bio-Rad Laboratories, Inc.). The filters for immunostaining were blocked with 2% BSA in 10 mm Tris-Cl buffer containing 0.1% Tween-20. After blocking, the blots were washed three times with wash buffer (5 min each), containing 10 mm Tris-Cl and 0.1% Tween-20, and were incubated with a mouse monoclonal anti-TSP1 antibody (NeoMarkers, Fremont, CA; Cat No: MS-421-P1, clone A6.1, 1:400 dilution) at 4 C overnight. The blots were then washed, incubated with peroxidaseconjugated sheep antimouse IgG (Amersham Life Sciences, Arlington Heights, IL) at room temperature for 1 h. After each antibody incubation, the blots were washed three times (15 min each) in wash buffer. The protein bands were visualized using an enhanced chemiluminescence Western blotting detection kit (Amersham). The molecular size of the proteins was determined by running standard molecular weight marker proteins (Bio-Rad Laboratories, Inc.) in an adjacent lane.
Immunocytochemistry
Frozen sections (4 m) of ovine myometrial tissue were immunostained for TSP1 using the avidin-biotin immunoperoxidase method. Briefly, sections were fixed in acetone for 10 min at room temperature and then rinsed twice in 0.05 m Tris buffered saline, 5 min each. Unless otherwise specified, all slides were sequentially incubated, for various times, at room temperature, with each of the following reagents: 1) 3% (vol/vol) H 2 O 2 in methanol for 30 min to block endogenous peroxidase activity; 2) 25% (vol/vol) normal horse serum and 5% (wt/vol) BSA in 0.05 m Tris-Cl with 0.15 m NaCl, pH 7.6, for 1 h; 3) mouse monoclonal anti-TSP1 antibody (1:400 dilution) described above as used for Western blotting, for 20 h at 4 C; 4) biotinylated horse antimouse IgG (Vector Laboratories, Inc., Burlingame, CA) for 0.5 h; 5) avidin-biotin complex (Vector Laboratories, Inc.): 40 l of each in 5 ml 0.05 m Tris-Cl, pH 7.6, for 0.5 h; and 6) 3,3-diaminobenzidine tetrahydrochloride (Sigma Chemical Co.) for 10 min: 4 g/10 ml 0.05 m Tris buffer (pH 7.6), to which was added 0.2 ml 3% H 2 O 2 . After each incubation, the slides were washed with Tris buffered saline for 15 min, except for step 2). The slides were then mounted in Permount with or without hematoxylin counterstaining. Specificity of immunostaining for the TSP1 was confirmed by three approaches: 1) omission of the primary antibody; 2) incubation of the 11-15) . B, The same blot was probed for 18S; C, densitometric analysis of the ratio of TSP1 mRNA and 18S rRNA in myometrium during both BPL and STL, compared with ECNL and TCNL (n ϭ 5 for each group). Significant increases were found in both groups of ewes in labor, when compared with ECNL and TCNL (mean Ϯ SEM). *, P Ͻ 0.01, BPL and STL vs. ECNL and TCNL. 13-18) . B, The same blot was probed for 18S; C, densitometric analysis of the ratio of TSP1 mRNA and 18S rRNA in myometrium from TCNL (n ϭ 6); STL (n ϭ 6), and Niminfused ewes (n ϭ 6). There was a significant increase in TSP1 mRNA during STL (**, P Ͻ 0.01). After NIM infusion, TSP1 mRNA decreased significantly in myometrium (*, P Ͻ 0.05; mean Ϯ SEM).
slides with the normal mouse serum instead of the primary antibody; and 3) Western blot analysis to determine the specificity of the antibody.
Statistical analysis
After normalization of the content of TSP1 mRNA to 18S rRNA in individual samples, TSP1 mRNA concentration in each Northern blot was expressed as a ratio of TSP1 mRNA to 18S rRNA. Differences between different groups for Northern blot or Western blot analysis were analyzed by ANOVA followed by multiple comparison using a Tukey-Kramer procedure. Data throughout are presented as the mean Ϯ sem. Figure 1 demonstrates the electrophoretic analysis of the secondary PCR product of SSH. There was a different banding pattern between the STL myometrial subtracted sample (lane 1), compared with the STL myometrial unsubtracted sample (lane 2). A 1.2-kb band, indicated by the white arrow, along with other bands of different sizes, can be identified clearly in the STL myometrial subtracted sample, indicating a great enrichment of differentially expressed genes in the subtracted sample. A dot blot of differential screening is shown in Fig. 2 . Duplicate blots were hybridized with forward-subtracted probes and reverse-subtracted probes, respectively. Dots hybridized with reverse-subtracted probes corresponded to background (Fig. 2) . Clones hybridized only with forward-subtracted probes represent mRNAs that were differentially expressed in the tester (STL) population of myometrium (Fig. 2) . Three of the clones representing the TSP1 gene were identified by sequence analysis and Blastn search.
Results
SSH
Northern blot analysis of TSP1
To further confirm the up-regulation of TSP1 mRNA in the pregnant sheep myometrium during labor, Northern blot analysis was performed. TSP1 mRNA was significantly increased in ovine myometrial tissue in BPL and in STL (Fig.  3) , indicating strong induction of an approximately 6.5-kb TSP1 mRNA in the myometrium in premature, as well as term, labor (P Ͻ 0.01). After nimesulide infusion, TSP1 mRNA was significantly decreased below levels seen in STL in the myometrium (Fig. 4) (P Ͻ 0.05) but remained significantly higher than TCNL ewes not in labor (P Ͻ 0.01).
Western blot analysis of TSP1
To test whether the mRNA changes were carried to the protein level, Western blot analysis was employed to evaluate TSP1 protein level in ovine myometrium, both before and during labor. In the pregnant sheep, myometrium immunoreactive TSP1 was expressed in the myometrium with molecular weights of approximate 120K (Fig. 5 ). An additional band at 140-kDa was observed in one myometrial sample. The immunoreactive band of TSP1 increased significantly (P Ͻ 0.001) in BPL or STL, which corresponds with the changes in TSP1 gene transcription observed by Northern blot analysis.
In situ hybridization and immunocytochemistry
In situ hybridization demonstrated that TSP1 mRNA was mainly associated with fibroblast-type cells in the myometrium (Fig. 6A) . However, some of myometrial cells also contained TSP1 mRNA (Fig. 6B) . Control sections treated with RNase A showed no specific signals (Fig. 6C) . Dense immunostaining for TSP1 was detected in the fibroblast-type cells, as well as in the extracellular matrix of the pregnant sheep myometrium (Fig. 6, D1 and D2) . Some of the myometrial cells were also stained for TSP1 (Fig. 6E) . When myometrial sections were reacted with the normal mouse serum as a replacement for the primary TSP1 antibody, the positive staining for TSP1 was abolished (Fig. 6F) .
Discussion
TSP1, a glycoprotein that is structurally and functionally similar to the adhesive glycoproteins, has been shown to modulate the attachment of a variety of cell types in vitro (24 -26) . Several integrin receptors have been reported to bind TSP1 (26, 27) , indicating its role in cell-matrix interactions. It has also been proposed that TSP1 plays a role in autocrine control of cell growth (28) . Furthermore, TSP1 may be an activator or stabilizer of TGF-␤ (29) .
Although the cell biology of TSP1 has been extensively studied at the molecular and cellular levels, changes in TSP1 in critical uterine tissues have not been studied in relation to pregnancy and parturition in any species. Throughout pregnancy, the myometrium is undergoing extensive biochemical and physiological changes. Myometrial activity initially remains relatively quiescent throughout pregnancy, demon- strating only irregular, long-lasting epochs of activity (contractures). At STL, the myometrium becomes active, developing regular contractions to expel the fetus (2) . The genes controlling these changes are poorly understood. SSH is a powerful and sensitive technique for rapidly identifying changes in abundance of mRNAs for individual genes during physiological events. It is a powerful method for studying the changing pattern of gene expression that allows identification of both known and previously undescribed mRNAs. Numerous cDNA subtraction methods have been reported (30 -32) . They are usually inefficient for obtaining low-abundance transcripts, and they require considerable amounts of poly-(A) ϩ RNA, involve multiple or repeated subtraction steps, and are labor intensive (23) . The mRNA differential display (33) and RNA fingerprinting by arbitrary primed PCR (34) are potentially faster methods for identifying differentially expressed genes. However, both of these methods have a high level of false positives (35, 36) and are biased for high copy number mRNA (37) .
Our study represents the first use of the SSH technique to examine transcript changes at the time of parturition. We demonstrated a marked increase of TSP1 associated with STL in myometrium collected from the central body of the pregnant uterus. Up-regulation of TSP1 mRNA in the pregnant sheep myometrium at STL, identified by SSH, was confirmed by Northern blot analysis. The demonstration that similar changes in TSP1 gene expression are associated with both STL and BPL supports the view that increased uterine TSP1 production plays an important role in the uterine changes that accompany labor, regardless of the manner in which labor is initiated.
It is interesting to note that inhibition of myometrial contraction by nimesulide resulted in the suppression of myometrial TSP1 expression during labor. The nimesulide infusion regimen that we used resulted in inhibition of myometrial contractility (38) and significantly inhibited PG production in the fetal circulation (39) . Thus, our findings provide further evidence of coupling of PG concentration and the progress of labor with the active synthesis of uterine labor-related genes, including TSP1. These findings indicate that uterine activation and stimulation are both required for the normal progression of labor.
We also report here that the increased TSP1 mRNA is carried to the protein level. TSP1 mRNA rose concurrently with TSP1 protein. The molecular weights we observed are consistent with the report that TSP1 is readily proteolyzed in tissue lysates, resulting in bands on Western blot of lower molecular weight (120 or 140K) than the intact 180K subunit (from the data sheet provided by the TSP1 antibody vendor). The mechanisms that up-regulate TSP1 production during labor are not defined. Parturition in sheep is accompanied by both a rise in estradiol and fall in progesterone in maternal plasma, together with changes in a large number of other potential regulators. The involvement of estradiol or/and progesterone in the regulation of increased TSP1 during labor awaits further study.
Increased TSP1 mRNA in the uterine lower segment, identified by Northern blot analysis, has been found in association with human labor (40) . In our study, we were able to evaluate changes in the body of the uterus, which plays a more active role in labor than the lower segment. Differential molecular mechanisms are associated with the regional control of contractility of the pregnant uterus; for example, inhibitory and contractile PG receptors are differentially distributed in the uterine corpus and fundus, compared with lower segment (41) . Therefore, the information obtained from uterine lower segment cannot be simply applied to the uterine corpus and fundus. In the current study, the increase in TSP1 mRNA was confirmed by three different molecular approaches: SSH, dot blot analysis, and Northern blot analysis. In addition, we quantitatively demonstrated, by Western blot analysis, that the increased TSP1 mRNA was accompanied by increased TSP1 protein. The function of upregulated myometrial TSP1 during parturition is not clear. Because TSP1 increases with labor in human myometrium (40) , we hypothesize that TSP1 may act as an indirect regulator of myometrial contractility. Further studies are needed to clarify the potential function of myometrial TSP1 in myometrial activation.
In the present study, we immunolocalized the TSP1 in the pregnant sheep myometrium. We validated the TSP1 antiserum, by Western blot, before performing immunocytochemistry, showing that the antiserum specifically hybridized to proteins with expected molecular weights. Determination of the precise distribution of TSP1 in pregnant sheep myometrium is essential for a complete understanding of TSP1's action in its target tissue. Specific immunostaining for TSP1 was mainly associated with fibroblasts in the pregnant sheep myometrium. However, myometrial cells also contained TSP1 localized by immunostaining. To further determine which cell type is responsible for producing TSP1, in situ hybridization was performed. Using in situ hybridization, TSP1 mRNA was identified mainly in fibroblasts; however, some myometrial cells also contained TSP1 mRNA, indicating that both fibroblasts and myometrial cells are involved in producing TSP1.
In conclusion: 1) our data provide the first evidence that changes in TSP1 mRNA and protein are associated with myometrial activation during both STL and BPL in sheep; 2) both myometrial fibroblasts and smooth muscle cells are responsible for producing TSP1; and 3) SSH is a powerful technique that enables us to study differentially regulated genes during labor.
